ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 50273 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 50273; 2) Community: the network communities that were significantly associated with the response to NSC 50273; 3) Molecule: the relationships between components within communities and NSC 50273; 4) MDR: the compounds that were significantly associated with the NSC 50273.

NSC Compound Enrichment Correlation
NSC 726770 Cis-6-(2-dimethylamino-1-ethyl)-5,6,12,13-tetrahydro-2,3-dim ethoxy-8,9-(methylenedioxy)-5,11-dioxo-11H-indeno-[1,2-c]iso quinoline 0.00910228844192553 0.29422673
NSC 726796 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3 (2H)-dione 0.00910228844192553 0.10273997
NSC 735169 3-(3,5-Bis-trifluoromethyl-phenylsulfanyl)-1-(4-chloro-pheny l)-propenone 0.00910228844192553 0.062255287
NSC 743874 Null 0.00910228844192553 0.1419205
NSC 762008 Copper(II) complex with a thiosemicarbazone as a ligand 0.00910228844192553 0.085649797
NSC 105132 Deoxycamptothecin 0.0091022884419256 0.43297515
NSC 135073 WITHACNISTIN 0.0091022884419256 -0.11889833
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.0091022884419256 0.037545527
NSC 350629 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester 0.0091022884419256 0.028156038
NSC 354051 LISCUNDITRIN 0.0091022884419256 -0.095052175
Total:106  Current:29    [First] [Prev] [Next] [Last]